Cite

HARVARD Citation

    Langford, C. et al. (2017). A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis. Arthritis & rheumatology. 69 (4), pp. 837-845. [Online]. 
  
Back to record